Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on July 10, 2025
Mindpeak Joins Techcyte Fusion Partner Program to Accelerate AI-Powered Digital Pathology
EIN Presswire
·
July 10, 2025
OREM, UT, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its Research Use Only (RUO) platform, Techcyte Fusion™, now includes …
IronCore Labs Announces Breakthrough with Cloaked AI: Encrypted Training Data Makes AI Models Safe and Private
EIN Presswire
·
July 10, 2025
IronCore Labs’ Cloaked AI now encrypts training data and models, ensuring AI privacy and security of production AI systems. BOULDER, CO, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- IronCore Labs today announced powerful new capabilities for its …
Expert strategies unveiled to tackle fractured instruments in dental procedures
EIN Presswire
·
July 10, 2025
GA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- An expert consensus addresses the critical issue of instrument separation during root canal therapy, a common complication that jeopardizes treatment success. The study provides a comprehensive …
Kelly Seitz’s Journey Featured in International #1 Bestselling Book 'Whispers of the Soul'
EIN Presswire
·
July 10, 2025
Massage therapist and sound healer shares her powerful way through grief and healing in the #1 international best seller "Whispers of the Soul" SHEBOYGAN FALLS, WI, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Licensed Massage Therapist and …
Cancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research
EIN Presswire
·
July 10, 2025
The escalating prevalence of cancer necessitates chemotherapy, intensifying its associated adverse effects …
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 10, 2025
BRISBANE, Calif. , July 10, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 6, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 133,500 shares of …
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
GlobeNewswire
·
July 10, 2025
Palo Alto, CA, July 10, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for the Centers for Medicare and Medicaid Services’ (CMS) …
Rheumatoid Arthritis and Muscle Wasting: New Review Points to Overlooked Complications
EIN Presswire
·
July 10, 2025
Researchers explore how rheumatoid arthritis causes muscle loss, uncovering complex mechanisms that may guide future treatments CHINA, July 10, 2025 /EINPresswire.com/ -- Myopenia, a condition marked by abnormal muscle loss, affects people across all …
ProcureTech Leaders Summit 2025 Announced: Where Procurement Meets Purpose, Innovation, and Impact
EIN Presswire
·
July 10, 2025
Join 150+ leaders in Frankfurt on 18 Sept for the ProcureTech Leaders Summit 2025, a one-day event focused on AI, ESG, and the future of procurement. FRANKFURT, FRANKFURT AM MAIN, GERMANY, July 10, 2025 /EINPresswire.com/ -- In an era defined by …
PubHive Wins Award for Innovative Literature Review Software
EIN Presswire
·
July 10, 2025
PubHive wins GHP's 2025 award for Most Innovative Literature Review Software, redefining life science workflows with AI-powered automation. LONDON, UNITED KINGDOM, July 10, 2025 /EINPresswire.com/ -- PubHive, the innovator behind the award-winning AI- …
NKGen Biotech Administers First Dose of Troculeucel to Alzheimer’s Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
GlobeNewswire
·
July 10, 2025
SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 10, 2025
SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Europe Pharmaceutical Drugs Market Expands with R&D Innovation, Biologics Growth, and Regulatory Harmonization 2025–2032
EIN Presswire
·
July 10, 2025
The Europe Pharmaceutical Drugs Market size is valued at USD 450 billion in 2025 and is expected to reach USD 610 billion by 2032, exhibiting a CAGR of 4.5%. BURLINGAME, CA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- The Europe Pharmaceutical …
Serina Therapeutics Makes Grant to New Employee Under Inducement Plan
GlobeNewswire
·
July 10, 2025
HUNTSVILLE, AL, July 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ …
Singapore’s Ministry of Health Signs Landmark Agreement to Become Pioneer Country in HealthAI Global Regulatory Network
EIN Presswire
·
July 10, 2025
Singapore’s participation underscores the growing international momentum behind responsible AI governance in health. SINGAPORE, SINGAPORE, July 10, 2025 /EINPresswire.com/ -- HealthAI - The Global Agency for Responsible AI in Health, today welcomes …
Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025
GlobeNewswire
·
July 10, 2025
ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to …
Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
July 10, 2025
Nasdaq compliance follows positive upward trend in Company’s Stock Price Jupiter, Florida, July 10, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL …
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
GlobeNewswire
·
July 10, 2025
SOUTH SAN FRANCISCO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …
Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy
GlobeNewswire
·
July 10, 2025
SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for …
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
July 10, 2025
WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously …